Real-World Clinical Outcomes in Asthmatic Patients Switched from Omalizumab to Anti-Interleukin-5 Therapy

Emily O’reilly; Deborah Casey; Hisham Ibrahim; Alice McGrath; Tomás McHugh; Punitha Vairamani; Jill Murphy; Barry Plant; Desmond M. Murphy

doi:10.2147/JAA.S358321

Real-World Clinical Outcomes in Asthmatic Patients Switched from Omalizumab to Anti-Interleukin-5 Therapy

Emily O’reilly
, Deborah Casey
, Hisham Ibrahim
, Alice McGrath
, Tomás McHugh
, Punitha Vairamani
, Jill Murphy
, Barry Plant
, Desmond M. Murphy

University College Cork

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	935-937
Number of pages	3
Journal	Journal of Asthma and Allergy
Volume	15
DOIs	https://doi.org/10.2147/JAA.S358321
Publication status	Published - 2022
Externally published	Yes

Access to Document

10.2147/JAA.S358321

Cite this

@article{c34b42f3aab3444f86d5927cc9a29b80,

title = "Real-World Clinical Outcomes in Asthmatic Patients Switched from Omalizumab to Anti-Interleukin-5 Therapy",

author = "Emily O{\textquoteright}reilly and Deborah Casey and Hisham Ibrahim and Alice McGrath and Tom{\'a}s McHugh and Punitha Vairamani and Jill Murphy and Barry Plant and Murphy, \{Desmond M.\}",

year = "2022",

doi = "10.2147/JAA.S358321",

language = "English",

volume = "15",

pages = "935--937",

journal = "Journal of Asthma and Allergy",

issn = "1178-6965",

}

TY - JOUR

T1 - Real-World Clinical Outcomes in Asthmatic Patients Switched from Omalizumab to Anti-Interleukin-5 Therapy

AU - O’reilly, Emily

AU - Casey, Deborah

AU - Ibrahim, Hisham

AU - McGrath, Alice

AU - McHugh, Tomás

AU - Vairamani, Punitha

AU - Murphy, Jill

AU - Plant, Barry

AU - Murphy, Desmond M.

PY - 2022

Y1 - 2022

UR - https://www.scopus.com/pages/publications/85134013892

U2 - 10.2147/JAA.S358321

DO - 10.2147/JAA.S358321

M3 - Letter

AN - SCOPUS:85134013892

SN - 1178-6965

VL - 15

SP - 935

EP - 937

JO - Journal of Asthma and Allergy

JF - Journal of Asthma and Allergy

ER -

Real-World Clinical Outcomes in Asthmatic Patients Switched from Omalizumab to Anti-Interleukin-5 Therapy

Access to Document

Other files and links

Cite this